Medical Digest & Congress Report

Professor Ingrid Pabinger held a presentation on extended anticoagulation in venous thromboembolism at the recent ESC Congress in Barcelona. We asked her to share the most important conclusions with us. Video:  https://congressreport.eu/scientific-contents/interview:facing-anticoagulation-dilemmas-venous-thromboembolism

Professor Dan Atar had an important presentation on the importance of optimal RAASi therapy in heart failure at this year’s ESC Congress. He is going to share his insights with us on the topic. Video: https://congressreport.eu/scientific-contents/interview:importance-optimal-raasi-therapy-heart-failure

Professor Athanasios J. Manolis chaired a very eye-opening session on how to improve care in patients with chronic coronry syndrome at this years ESC Congress. We asked him to share his insights with us on the topic. Video: https://congressreport.eu/scientific-contents/interview:chronic-coronary-syndrome-re-thinking-treatment-management-and-outcome-priorities

Professor Roxana Mehran chaired a very special Guidelines in Practice session at this year’s ESC Congress on dual antiplatelet therapy. We asked her to share the most important conclusions with us. Video:  https://congressreport.eu/scientific-contents/interview:dual-antiplatelet-therapy-practice

Professor Marion Delcroix co-chareid the session presenting the 2022 ESC-ERS guideline for the diagnosis and treatment of pulmonary hypertension at this year’s ESC congress. We asked her to highlighting the most important points of the new recommendations. Video: https://congressreport.eu/scientific-contents/interview:2022-esc-ers-guidelines-diagnosis-and-treatment-pulmonary-hypertension

Professor Ricardo Asteggiano chaired a guideline is practice session on the management of dyslipidaemias in the elderly at this years ESC Congress. We asked him to share the most important conclusions with us. Video: https://congressreport.eu/scientific-contents/interview:guidelines-practice-management-dyslipidaemias-elderly

Professor Robert Storey co-chaired a very interesting Guidelines in Practice session on dual antiplatelet therapy at this year’s ESC Congress.  The session was started with a case presentation of a patient undergoing complex PCI for NSTE-ACS with high risk both for bleeding and trombotic complications. Video: https://congressreport.eu/scientific-contents/interview:guidelines-practice-dual-ant...

Professor Mamas Mamas chaired a very interesting interactive session at this years ESC Congress in Barcelona. We asked him to share his insights with us on the topic. Video: https://congressreport.eu/scientific-contents/interview:getting-ldl-c-goals-and-staying-there-long-term

Professor George Bakris chaired a very interesting session at the recent ESC Congress on the Cardiorenal benefits of finerenone, which is indicated for the treatment of chronic kidney disease associated with type 2 diabetes. We asked him for sharing his insights ont he topic. Video: https://congressreport.eu/scientific-contents/interview:cardiorenal-benefits-finerenone-protecting-heart-and-kidneys

Dr. Maria Elisa Mancuso chaired a symposium at the recent ISTH 2022 congress. The main topic was to try to understand which are the clinical met needs of haemophilia care. Video: https://congressreport.eu/scientific-contents/interview:journey-address-unmet-needs-across-all-haemophilia-indications

We asked Professor Heleen van Ommen about a symposium presented on the ISTH 2022 congress in London, which was about pediatric thrombosis. Video: https://congressreport.eu/scientific-contents/interview:anticoagulant-advancements-vte-children

Professor Walter Ageno shared us his thoughts on a symposium he took part on the recent ISTH 2022 congress, which addressed very practical issues in the management of patients with venous thromboembolism. Video: https://congressreport.eu/scientific-contents/interview:clinical-challenges-patients-venous-thromboembolism

Professor Alex Spyropoulos shared with us the guidance statement of the Scientific Standardization Committee of the ISTH about the good practice statements for antithrombotic therapy in the management of COVID-19. These statement was presented at the ISTH 2022 Congress in London. For more details, read the full article on the page of the Journal of Thrombosis and Haemostasis: https://onlinelibrary...

Professor Ishac Nazy held an interesting symposium durint the recent ISTH 2022 congress. He shared us his thought about ISTH proposal to standardize functional assays in the diagnosis of Heparin‐induced Thrombocytopenia. Video: https://congressreport.eu/scientific-contents/interview:isth-proposal-standardize-functional-assays-diagnosis-heparininduced-thrombocytopenia

Professor Margareth C. Ozelo shared us his thought about a symposium held at the recent ISTH 2022, which topic was about general issues related to joint health for hemophilia patient. Video:  https://congressreport.eu/scientific-contents/interview:navigating-joint-health-journey-patients-hemophilia-how-can-you-make-lasting-impact

Professor Deborah Siegal chaired an interesting symposium during the ISTH 2022 congress in London, the topic was strategies for assessing and managing DOAC-related bleeding. Video: https://congressreport.eu/scientific-contents/interview:strategies-assessing-and-managing-doac-related-bleeding

Professor Johnny Mahlangu shared with us a symposium that they organized during the ISTH 2022 congress. They examined approaches to standardisation and monitoring for Haemophilia Gene Therapy. Video: https://congressreport.eu/scientific-contents/interview:approaches-standardisation-and-monitoring-haemophilia-gene-therapy-consistency-considerations-and-challenges

We asked Dr. Emma Leitinger about their work which was presented as a poster at the recent ISTH 2022 congress. Video: https://congressreport.eu/scientific-contents/interview:comparison-between-full-dose-and-reduced-dose-enoxaparin-management-cancer-associated-venous-thromboembolism

We asked Professor Antonia Follenzi about their research data on the role of Factor VIII, what she presented on the recent ISTH 2022 congress in London. Video: https://congressreport.eu/scientific-contents/interview:roles-fviii-endothelial-cell-biology-more-coagulation-factor

Professor Paolo Mulatero co-chaired a Meet the Expert session about the novelties diagnosis and management of primary aldosteronism at the recent ESH 2022. Video: https://congressreport.eu/scientific-contents/interview:diagnosis-and-management-primary-aldosteronism

We asked Professor Michel Burnier about the adherence to antihypertensive treatment in patients with CKD, what he presented at the ESH Working Group on Hypertension and Kidney during the recent European Socity of Hypertension congress in Athens. Video: https://congressreport.eu/scientific-contents/interview:adherence-antihypertensive-treatment-patients-ckd-barrier-optimal-renoprotection

We asked Professor Philip Haddad about anticoagulation treatment of patients with brain tumor. Professor Haddad presented a meta-analysis of the use of DOACs versus LMWH in this indication at the recent ISTH congress Video: https://congressreport.eu/scientific-contents/interview:brain-cancers-and-risk-intracranial-hemorrhage-direct-oral-anticoagulants-versus-low-molecular-weight-heparin

Professor Gianfranco Parati took part in many interesting sessions during the recent European Society of Hypertension. We asked to share his insight on the novelties from ESH 2022 with the audience. Video:  https://congressreport.eu/scientific-contents/interview:special-forms-hypertension-optomized-prevention-and-hypertension-epidemiology-novelties-esh-2022

Professor Saskia Middeldorp presented the result of the Highlow Study at the recent ISTH 2022 congress in London, which investigated the different dosages of low molecular weight heparins in pregnant pregnant and postpartum women with a history of venous thromboembolism. Video: https://congressreport.eu/scientific-contents/interview:ten-months-needles-wed-better-get-it-right-highlow-study

We asked Professor Sam Schulman about the ISTH Guidelines on antithrombotic treatment in COVID-19. Video: https://congressreport.eu/scientific-contents/interview:isth-guidelines-anticoagulation-covid-19